GCMI CEO Sherry Farrugia Named 2023 Recipient of the Center for Global Health Innovation’s Highest Honor, the Industry Growth Award.

The Center for Global Health Innovation (CGHI) recently announced the winners of its 2023 Golden Helix Awards. Congratulations to GCMI’s CEO, Sherry Farrugia, recipient of the 2023 Industry Growth Awards for her impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by CGHI.  …

Ortho Innovators: Advance Your Technology, at Any Phase in Its Pathway, by Connecting with GCMI at ORS 2023

If you’re attending ORS 2023 and have a new orthopedic technology in development, including preclinical work that may be on your product development horizon, you have a wonderful chance to connect with our Director of Scientific Affairs Evan Goldberg onsite.   GCMI is the U.S. proving ground for global medical innovation. Our mission is to…

Aligned Career Opportunity: Project Manager to Advance Research and Education in Neuroscience.

Our colleague Chris Rozell, Professor and Julian T. Hightower Chair,Technical Interest Groups: Bioengineering, Digital Signal Processing at Georgia Tech asked us to share the following career opportunity advancing research and education in neuroscience. We hope this initiative and position will have the opportunity to work closely with GCMI in the future. From Chris: Georgia Tech…

Come work with our industry leading medtech innovation design and development team – Seeking a senior research engineer to join the GCMI team

GCMI, a non-profit affiliate of the Georgia Institute of Technology, is actively recruiting for a research engineer to lead multiple new medtech product development projects.   The medical device design services and product development team at GCMI facilitates medical product development through all phases – from initial concept generation through transfer to production manufacturing. We…

Aligned in Acceleration: An Introduction to Our Colleagues at Within3, Their Insights Management Platform and Its Potential Implications for Preclinical Testing

Our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement with key opinion leaders in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…

Preclinical Implications for 3D Printed and Bioresorbable Medical Technologies

The phrase “personalized medicine” has been thrown about by so many for so long in healthcare as to defy definition: or require post graduate work in any one of dozens of specific clinical or technological fields.   For the sake of brevity, 3D printing and bioresorbable material technologies are actively realizing personalized medicine in the…

Quite a Ride! Meet the GCMI Team: Saylan Lukas, Director of Research and Development Engineering

So many engineers probably wanted to be an astronaut as kids at some point or another. Saylan Lukas wanted to design roller coasters.   Fortunately for GCMI, our clients and patients benefiting from novel medical technologies, Saylan’s elective in Biomedical Engineering taught by Dr. Sam Hulbert at Rose-Hulman Institute of Technology shifted his career course…

New Technologies for Neurosurgery, Urology and Endoscopy Earn Inaugural I3 GCMI Research Awards

“In partnership with Georgia CTSA (Clinical and Translational Science Alliance), the I3 (Imagine, Innovate, and Impact) GCMI Research Awards are intended to spark synergistic interactions among investigators from the Emory School of Medicine (SOM) with Georgia Tech affiliate the Global Center for Medical Innovation (GCMI). Proposals are envisioned to improve patient care by more effectively…

Early, consistent focus on the unmet need keeps Augment Health on a solid commercialization pathway

“When your ‘north star’ is doing what’s right for the patient and the user, everything else can follow. The best way to accelerate clinical adoption and utility is to prove your early hypotheses, generate data and gather clinical input.”